1. What is CD68/SR-D1? What are its basic structure and localization?

CD68 (also known as SR-D1) is a highly glycosylated transmembrane protein belonging to the scavenger receptor (SR) D family. Its gene is located on human chromosome 17p13. The protein structure includes a lysosome-associated membrane protein (LAMP)-like domain and multiple glycosylation sites, which allow it to localize primarily to intracellular lysosomes and the cell membrane. CD68/SR-D1 is highly expressed in macrophages and their precursors (such as monocytes), making it widely used as a marker for macrophages. Through immunohistochemical staining (e.g., anti-CD68 antibody staining), researchers can visually identify the distribution of macrophages in tissues.

2. What functions does CD68/SR-D1 serve in the immune system?

The core function of CD68/SR-D1 is as a scavenger receptor involved in innate immune responses. It recognizes and binds to various "non-self" or "modified self" molecules, such as oxidized low-density lipoprotein (oxLDL), bacterial lipopolysaccharide (LPS), and apoptotic cell debris. By endocytosing these substances, CD68/SR-D1 helps clear pathogens and cellular waste, maintaining tissue homeostasis. Additionally, it may indirectly regulate inflammatory responses—for example, in atherosclerosis, CD68-mediated oxLDL phagocytosis promotes the transformation of macrophages into foam cells, thereby exacerbating inflammation. In infections, it enhances bacterial clearance.

3. Which diseases are closely associated with CD68/SR-D1?

Abnormal expression or dysfunction of CD68/SR-D1 is linked to several diseases:

Atherosclerosis: Macrophages phagocytose oxLDL via CD68/SR-D1, forming foam cells, which are core components of arterial plaques. Studies show that inhibiting CD68 can reduce plaque formation.

Cancer: In many tumors (such as breast and colon cancer), tumor-associated macrophages (TAMs) highly express CD68, and their density often correlates with tumor progression and poor prognosis. These cells may promote immunosuppression and angiogenesis.

Autoimmune diseases: In rheumatoid arthritis or inflammatory bowel disease, infiltration of CD68+ macrophages is positively correlated with tissue damage and chronic inflammation.

Infectious diseases: As a pattern recognition receptor, CD68/SR-D1 participates in immune responses against bacteria, viruses, and fungi, though its specific mechanisms are still under investigation.

4. How is CD68/SR-D1 used as a biomarker for diagnosis or research?

Due to its specific expression in macrophages, CD68/SR-D1 has become an important biomarker in clinical and research settings:

Pathological diagnosis: Immunohistochemical detection of CD68 expression in tissue sections helps diagnose inflammatory diseases (e.g., granulomatous lesions) or assess immune cell infiltration in tumor microenvironments.

Research tool: In animal models or cell experiments, CD68 antibodies are commonly used to track macrophage activation states or distribution changes. Flow cytometry also utilizes CD68 to sort macrophage populations.
It is worth noting that CD68 is not the only marker for macrophages (others like CD14 and CD163 are also commonly used), so combining multiple markers improves accuracy.

5. What are the current research frontiers targeting CD68/SR-D1?

Recent research focuses on the regulatory mechanisms and application potential of CD68/SR-D1:

Targeted therapy: In cancer immunotherapy, scientists are developing drugs targeting CD68+ macrophages, such as antibody-drug conjugates (ADCs) to specifically eliminate pro-tumor macrophages or block their scavenger function to slow atherosclerosis.

Genetic regulation: Studies have found that inflammatory signals (e.g., IFN-γ or TNF-α) can upregulate CD68 expression, and epigenetic modifications may also affect its transcription, offering new targets for disease intervention.

Cross-species research: CD68 is conserved in mammals, but its function varies slightly across species (e.g., mice vs. humans). Comparative studies help understand immune evolution.

6. How does CD68/SR-D1 compare to other scavenger receptors?

The scavenger receptor family includes classes A, B, C, D, and more. CD68/SR-D1 belongs to class D. Compared to SR-A (e.g., SR-A1) or SR-B (e.g., CD36), CD68/SR-D1 is more associated with lysosomal linkage and endocytic functions, while CD36 is more involved in lipid metabolism. Additionally, CD68 has a narrower expression range (mainly limited to macrophages), whereas other receptors may be expressed in broader cell types (e.g., endothelial or smooth muscle cells). Functionally, they overlap but are not redundant—for example, in atherosclerosis, CD68 and CD36 synergistically promote oxLDL uptake.

Conclusion

As a multifunctional macrophage marker and scavenger receptor, CD68/SR-D1 plays a dual role in immune homeostasis and disease progression. From basic research to clinical applications, in-depth exploration of its mechanisms not only broadens our understanding of macrophage biology but also offers new avenues for treating inflammation, cancer, and metabolic diseases. In the future, with advances in single-cell technologies and targeted therapies, CD68/SR-D1 is expected to become a key component of precision medicine.

技术文章